MSB 1.02% 97.0¢ mesoblast limited

Ann: FDA Notifies Clinical Data Sufficient for Refiling aGVHD BLA, page-106

  1. 2,657 Posts.
    lightbulb Created with Sketch. 1705
    Yep ten million spent on potency data assays is smoke and mirrors

    FDA not questioning efficacy in the CRL is sorcery

    But you do hope it is approved

    Reg
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
(20min delay)
Last
97.0¢
Change
-0.010(1.02%)
Mkt cap ! $1.107B
Open High Low Value Volume
98.0¢ 98.5¢ 95.5¢ $6.248M 6.438M

Buyers (Bids)

No. Vol. Price($)
1 10000 96.5¢
 

Sellers (Offers)

Price($) Vol. No.
97.0¢ 116040 7
View Market Depth
Last trade - 16.10pm 26/06/2024 (20 minute delay) ?
MSB (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.